Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients With de Novo Native Coronary Artery Lesions (SPIRIT III: 8-Month and 2-Year Results ...
Thus far, the most comprehensive clinical trial data from commercially available bioabsorbable polymer DES, relate to the stents of the ... Nobori with Cypher and Xience™. Such data, in addition ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback